Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Precision Medicine, “My Hope for the Future”

A meeting on Capitol Hill in Washington, D.C. today heard about one person’s struggle with cystic fibrosis and her hope for precision medicine to provide a cure. . . . → Read More: Precision Medicine, “My Hope for the Future”

Process Converts Food Waste to Auto Tire Materials

Agricultural scientists in Ohio are developing a process for converting common food waste into materials used in car tires, and filed a patent for these techniques. . . . → Read More: Process Converts Food Waste to Auto Tire Materials

Air Sampling Device Finds Unreported Allergens

A system designed to sample the air in homes of people with allergies found a number of airborne allergens in residences that previously went undetected by other devices. . . . → Read More: Air Sampling Device Finds Unreported Allergens

Trial Underway to Test Cancer Immunotherapy Aid

A clinical trial began recruiting participants with advanced tumors to test a compound that helps treatments for cancer harnessing the immune system. . . . → Read More: Trial Underway to Test Cancer Immunotherapy Aid

Messenger RNA Engineered to Produce Antibodies

Academic and industry researchers demonstrated production of therapeutic antibodies inside cells of lab mice, offering a simpler and lower-cost alternative to monoclonal antibodies. . . . → Read More: Messenger RNA Engineered to Produce Antibodies

Biotech Companies to Discover Ebola, Zika Vaccines

Two biotechnology companies are collaborating to discover new vaccines protecting against Ebola and Zika viruses that present global threats to public health. . . . → Read More: Biotech Companies to Discover Ebola, Zika Vaccines

Mobile App-Controlled Patch Reduces Migraine Pain

A patch worn on the arm providing stimulation to nerve cells was shown in a clinical trial to reduce the amount of pain experienced by people with migraines. . . . → Read More: Mobile App-Controlled Patch Reduces Migraine Pain

Cancer Blood Test Company Raises $65M in Early Funds

Freenome, a company applying machine learning to analysis of liquid biopsies, is raising $65 million in its first round of venture financing. . . . → Read More: Cancer Blood Test Company Raises $65M in Early Funds

Engineered T-Cells Shown Reducing Non-Hodgkin Lymphoma

A clinical trial testing synthetic immune system cells shows after 6 months the cells can generate a full or partial response in many patients with non-Hodgkin lymphoma. . . . → Read More: Engineered T-Cells Shown Reducing Non-Hodgkin Lymphoma